The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
Open accessAbstract
As a progressive chronic disease, age-related macular degeneration (AMD) is the leading cause of irreversible vision impairment worldwide. Experimental and clinical evidence has demonstrated that vascular endothelial growth factor (VEGF) plays a vital role in the formation of choroidal neovascularization. Intravitreal injections of anti-VEGF agents have been recommended as a first-line treatment for neovascular AMD. However, persistent fluid or recurrent exudation still occurs despite standardized anti-VEGF therapy. Patients suffering from refractory or recurrent neovascular AMD may develop mechanisms of resistance to anti-VEGF therapy, which results in a diminished therapeutic effect. Until now, there has been no consensus on the definitions of refractory neovascular AMD and recurrent neovascular AMD. This article aims at clarifying these concepts to evaluate the efficacy of switching drugs, which contributes to making clinical decision more scientifically. Furthermore, insight into the causes of resistance to anti-VEGF therapy would be helpful for developing possible therapeutic approaches, such as combination therapy and multi-target treatment that can overcome this resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
Papadopoulos, N., Martin, J., Ruan, Q., Rafique, A., Rosconi, M. P., Shi, E., Pyles, E. A., Yancopoulos, G. D., Stahl, N., & Wiegand, S. J. (2012) · Angiogenesis · doi:10.1007/s10456-011-9249-6 · Cited by 1,037
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Wordsworth, S., & Reeves, B. C. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.015 · Cited by 781
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 757
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.017 · Cited by 683
Ho, A. C., Busbee, B. G., Regillo, C. D., Wieland, M. R., Van Everen, S. A., Li, Z., Rubio, R. G., & Lai, P. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.009 · Cited by 590
Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18549 · Cited by 562
(1965) · Nature · doi:10.1038/205236a0 · Cited by 560
Clinical Characteristics of Exudative Age-related Macular Degeneration in Japanese Patients
Maruko, I., Iida, T., Saito, M., Nagayama, D., & Saito, K. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.03.047 · Cited by 544
Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., Ezzat, M. K., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.09.012 · Cited by 541
Polypoidal Choroidal Vasculopathy
Cheung, C. M. G., Lai, T. Y. Y., Teo, K., Ruamviboonsuk, P., Chen, S.-J., Kim, J. E., Gomi, F., Koh, A. H., Kokame, G., Jordan-Yu, J. M., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.08.006 · Cited by 519
Busbee, B. G., Ho, A. C., Brown, D. M., Heier, J. S., Suñer, I. J., Li, Z., Rubio, R. G., & Lai, P. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.014 · Cited by 500 · cited 1×
“permeability and persistent exudation that is no longer amenable to anti-VEGF therapy.(101) Inflammatory stimulation could also increase fibrosis of the CNV, which acts as a resorption barrier and decreases patients’ sensitivity to antiVEGF drugs.”
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
Polypoidal Choroidal Vasculopathy: Incidence, Demographic Features, and Clinical Characteristics
Sho, K. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.10.1392 · Cited by 439
Spilsbury, K., Garrett, K. L., Shen, W.-Y., Constable, I. J., & Rakoczy, P. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64525-7 · Cited by 394
Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
Bloch, S. B., Larsen, M., & Munch, I. C. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.10.016 · Cited by 377
Predicted biological activity of intravitreal VEGF Trap
Stewart, M. W., & Rosenfeld, P. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.134874 · Cited by 375
Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration
Seddon, J. M., Francis, P. J., George, S., Schultz, D. W., Rosner, B., & Klein, M. L. (2007) · JAMA · doi:10.1001/jama.297.16.1793 · Cited by 330
Outer Retinal Tubulation: A Novel Optical Coherence Tomography Finding
Zweifel, S. A. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.326 · Cited by 325
Ying, G.-S., Huang, J., Maguire, M. G., Jaffe, G. J., Grunwald, J. E., Toth, C., Daniel, E., Klein, M., Pieramici, D., Wells, J., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.042 · Cited by 305
Polypoidal choroidal vasculopathy
Ciardella, A. P., Donsoff, I. M., Huang, S. J., Costa, D. L., & Yannuzzi, L. A. (2004) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2003.10.007 · Cited by 305
TYPE 3 NEOVASCULARIZATION: The Expanded Spectrum of Retinal Angiomatous Proliferation
FREUND, K. B., -VAN HO, I., BARBAZETTO, I. A., KOIZUMI, H., LAUD, K., FERRARA, D., MATSUMOTO, Y., SORENSON, J. A., & YANNUZZI, L. (2008) · Retina · doi:10.1097/iae.0b013e3181669504 · Cited by 295
Expression of vascular endothelial growth factor in experimental choroidal neovascularization
Ishibashi, T., Hata, Y., Yoshikawa, H., Nakagawa, K., Sueishi, K., & Inomata, H. (1997) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00941723 · Cited by 256
Bakall, B., Folk, J. C., Boldt, H. C., Sohn, E. H., Stone, E. M., Russell, S. R., & Mahajan, V. B. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.02.017 · Cited by 229
Stewart, M. W., Rosenfeld, P. J., Penha, F. M., Wang, F., Yehoshua, Z., Bueno-Lopez, E., & Lopez, P. F. (2011) · Retina · doi:10.1097/iae.0b013e31822c290f · Cited by 225
Deep Retinal Vascular Anomalous Complexes in Advanced Age-related Macular Degeneration
Hartnett, M. E., Weiter, J. J., Staurenghi, G., & Elsner, A. E. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30389-8 · Cited by 216
Schaal, S., Kaplan, H. J., & Tezel, T. H. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.07.007 · Cited by 209
GAUDREAULT, J., FEI, D., BEYER, J. C., RYAN, A., RANGELL, L., SHIU, V., & DAMICO, L. A. (2007) · Retina · doi:10.1097/iae.0b013e318134eecd · Cited by 181
TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
FOROOGHIAN, F., CUKRAS, C., MEYERLE, C. B., CHEW, E. Y., & WONG, W. T. (2009) · Retina · doi:10.1097/iae.0b013e3181a2c1c3 · Cited by 179
Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration
Li, X., Xu, G., Wang, Y., Xu, X., Liu, X., Tang, S., Zhang, F., Zhang, J., Tang, L., Wu, Q., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.03.026 · Cited by 179
Kumar, N., Marsiglia, M., Mrejen, S., Fung, A. T.-C., Slakter, J., Sorenson, J., & Freund, K. B. (2013) · Retina · doi:10.1097/iae.0b013e31828e8551 · Cited by 177
Subtype lesions of neovascular age-related macular degeneration in Chinese patients
Liu, Y., Wen, F., Huang, S., Luo, G., Yan, H., Sun, Z., & Wu, D. (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0575-8 · Cited by 176
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
Gasperini, J. L., Fawzi, A. A., Khondkaryan, A., Lam, L., Chong, L. P., Eliott, D., Walsh, A. C., Hwang, J., & Sadda, S. R. (2012) · British Journal of Ophthalmology · doi:10.1136/bjo.2011.204685 · Cited by 175
Imaging of Chorioretinal Anastomoses in Vascularized Retinal Pigment Epithelium Detachments
Kuhn, D. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100110052025 · Cited by 171
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
Binder, S. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301236 · Cited by 169
Souied, E. H., Leveziel, N., Richard, F., Dragon‐Durey, M., COSCAS, G. J., Soubrane, G., Benlian, P., & Frémeaux‐Bacchi, V. (2005) · Molecular vision · Cited by 168
Yonekawa, Y., Andreoli, C., Miller, J. B., Loewenstein, J. I., Sobrin, L., Eliott, D., Vavvas, D. G., Miller, J. W., & Kim, I. K. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.03.030 · Cited by 166
Clinical update: new treatments for age-related macular degeneration
Wong, T. Y., Liew, G., & Mitchell, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61104-0 · Cited by 166
Cho, M., Barbazetto, I. A., & Freund, K. B. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.02.012 · Cited by 166
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
Cho, H., Shah, C. P., Weber, M., & Heier, J. S. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303344 · Cited by 161
Review of Retinal Angiomatous Proliferation or Type 3 Neovascularization
Yannuzzi, L. A., Freund, K. B., & Takahashi, B. S. (2008) · Retina · doi:10.1097/iae.0b013e3181619c55 · Cited by 157
Ranibizumab for Neovascular Age-Related Macular Degeneration
Liew, G., & Mitchell, P. (2007) · New England Journal of Medicine · doi:10.1056/nejmc063011 · Cited by 156
Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
Chang, A., Li, H., Broadhead, G., Hong, T., Schlub, T. E., Wijeyakumar, W., & Zhu, M. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.035 · Cited by 154
Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients
Byeon, S. H., Lee, S. C., Oh, H. S., Kim, S. S., Koh, H. J., & Kwon, O. W. (2008) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-007-0498-2 · Cited by 150
Keane, P. A., Liakopoulos, S., Ongchin, S. C., Heussen, F. M., Msutta, S., Chang, K. T., Walsh, A. C., & Sadda, S. R. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1689 · Cited by 145
Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
Eghøj, M. S., & Sørensen, T. L. (2012) · British Journal of Ophthalmology · doi:10.1136/bjo.2011.203893 · Cited by 143
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
VANDER, J. F. (2012) · Yearbook of Ophthalmology · doi:10.1016/j.yoph.2011.12.002 · Cited by 138
Polypoidal choroidal vasculopathy in elderly Chinese patients
Wen, F., Chen, C., Wu, D., et al. (2004) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-003-0667-z · Cited by 137
Lee, A. Y., Raya, A. K., Kymes, S. M., Shiels, A., & Brantley, M. A. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.150995 · Cited by 134
Rusnati, M., & Presta, M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039689 · Cited by 133
Ho, V. Y., Yeh, S., Olsen, T. W., Bergstrom, C. S., Yan, J., Cribbs, B. E., & Hubbard, G. B. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.02.009 · Cited by 132
One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Yamamoto, A., Okada, A. A., Kano, M., Koizumi, H., Saito, M., Maruko, I., Sekiryu, T., & Iida, T. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.05.024 · Cited by 129
Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration
Bottoni, F. G. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.12.1644 · Cited by 128
Kuroda, Y., Yamashiro, K., Miyake, M., Yoshikawa, M., Nakanishi, H., Oishi, A., Tamura, H., Ooto, S., Tsujikawa, A., & Yoshimura, N. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.06.053 · Cited by 119
Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells
Wu, E., Palmer, N., Tian, Z., Moseman, A. P., Galdzicki, M., Wang, X., Berger, B., Zhang, H., & Kohane, I. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003794 · Cited by 118
Time Trends in the Incidence and Causes of Blindness in Israel
Skaat, A., Chetrit, A., Belkin, M., Kinori, M., & Kalter-Leibovici, O. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.035 · Cited by 115
Phenotype and Genotype Characteristics of Age-related Macular Degeneration in a Japanese Population
Mori, K., Horie‐Inoue, K., Gehlbach, P. L., Takita, H., Kabasawa, S., Kawasaki, I., Ohkubo, T., Kurihara, S., Iizuka, H., Miyashita, Y., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.10.001 · Cited by 115
Profile of conbercept in the treatment of neovascular age-related macular degeneration
Sun, X., & Lu, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s67536 · Cited by 114
Self-citationRanibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
VANDER, J. F. (2007) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)70110-2 · Cited by 114
Zhang, M., Yu, D., Yang, C., Xia, Q., Li, W., Liu, B., & Li, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9718-9 · Cited by 112
Polypoidal Choroidal Vasculopathy in Asians
Wong, C. W., Wong, T. Y., & Cheung, C. M. G. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050782 · Cited by 107
Mechanisms of resistance to vascular endothelial growth factor blockade
Abdullah, S. E., & Perez-Soler, R. (2011) · Cancer · doi:10.1002/cncr.26540 · Cited by 105
Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
Huang, J., Soffer, S. Z., Kim, E. S., McCrudden, K. W., Huang, J. T., New, T. N., Manley, C. A., Middlesworth, W., O’Toole, K., Yamashiro, D. J., et al. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.36.2.1 · Cited by 101
Campa, C., Costagliola, C., Incorvaia, C., Sheridan, C., Semeraro, F., Nadai, K. D., Sebastiani, A., & Parmeggiani, F. (2010) · Mediators of Inflammation · doi:10.1155/2010/546826 · Cited by 98
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
Ehlken, C., Jungmann, S., Böhringer, D., Agostini, H. T., Junker, B., & Pielen, A. (2014) · Eye · doi:10.1038/eye.2014.64 · Cited by 95
Arcinue, C. A., Ma, F., Barteselli, G., Sharpsten, L., Gomez, M. L., & Freeman, W. R. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.11.022 · Cited by 93
Wykoff, C. C., Brown, D. M., Maldonado, M. E., & Croft, D. E. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304736 · Cited by 93
Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit
Li, H., Lei, N., Zhang, M., Li, Y., Xiao, H., & Hao, X. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.09.002 · Cited by 92
Brown, D. M., Chen, E., Mariani, A., & Major, J. C. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.08.008 · Cited by 90
Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
Georgalas, I., Perganta, Vakalis, Vachtsevanos, Tranos, Asteriades, S., & Koukoula (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s43470 · Cited by 81
Grewal, D. S., Gill, M. K., Sarezky, D., Lyon, A. T., & Mirza, R. G. (2014) · Eye · doi:10.1038/eye.2014.101 · Cited by 80
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Fassnacht-Riederle, H., Becker, M. D., Graf, N., & Michels, S. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2589-3 · Cited by 80
Singh, R. P., Srivastava, S. K., Ehlers, J. P., Bedi, R., SCHACHAT, A. P., & Kaiser, P. K. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304798 · Cited by 77
(2000) · Time to knit · doi:10.1016/j.yoph.2014.02.025 · Cited by 76
Abedi, F., Wickremasinghe, S., Richardson, A. J., Islam, A. F. M., Guymer, R. H., & Baird, P. N. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.014 · Cited by 74
Freund, K. B. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.4.487 · Cited by 69
Emerging Therapies for Neovascular Age-Related Macular Degeneration
Kaiser, P. K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.061 · Cited by 68
Tozer, K. R., Roller, A. B., Chong, L. P., Sadda, S. R., Folk, J. C., Mahajan, V. B., Russell, S. R., Boldt, H. C., & Sohn, E. H. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.016 · Cited by 66
Sloan, F. A., & Hanrahan, B. W. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7647 · Cited by 65
Broadhead, G., Hong, T., & Chang, A. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12463 · Cited by 61
Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
Pinheiro-Costa, J., Costa, J. M. M., Beato, J. N., Freitas‐da‐Costa, P., Brandão, E., Falcão, M. S., Falcão‐Reis, F., & Carneiro, Â. M. (2015) · Ophthalmologica · doi:10.1159/000381221 · Cited by 60
Dansingani, K. K., Naysan, J., & Freund, K. B. (2015) · Eye · doi:10.1038/eye.2015.27 · Cited by 60
Gharbiya, M., Iannetti, L., Parisi, F., Vico, U. D., Mungo, M. L., & Marenco, M. (2014) · BioMed Research International · doi:10.1155/2014/273754 · Cited by 59
Cheung, C. M. G., Li, X., Mathur, R., Lee, S. Y., Chan, C. M., Yeo, I. Y. S., Loh, B. K., Williams, R. E., Wong, E. Y., Wong, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101057 · Cited by 58
Wu, Z., Zhou, P., Li, X., Wang, H., Luo, D., Qiao, H., Ke, X., & Huang, J. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057642 · Cited by 56
Polypoidal Choroidal Vasculopathy in Taiwanese Patients
Chang, Y., & Wu, W.-C. (2009) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20091030-07 · Cited by 56
The Role of the Complement System in Age-Related Macular Degeneration
Weber, B. H. F., Issa, P. C., Pauly, D., Herrmann, P., Graßmann, F., & Holz, F. G. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0133 · Cited by 55
Fung, A. T.-C., Kumar, N., Vance, S. K., Slakter, J. S., Klancnik, J. M., Spaide, R. F., & Freund, K. B. (2012) · Eye · doi:10.1038/eye.2012.174 · Cited by 55
Chen, H., Yu, K., & Xu, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042464 · Cited by 54
Hemeida, T. S., Keane, P. A., Dustin, L., Sadda, S. R., & Fawzi, A. A. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.167627 · Cited by 54
Heussen, F. M., Shao, Q., Ouyang, Y., Joussen, A. M., & Müller, B. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2553-7 · Cited by 52
Messenger, W., Campbell, J. P., Faridi, A., Shippey, L., Bailey, S. T., Lauer, A. K., Flaxel, C. J., & Hwang, T. S. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304829 · Cited by 50
Combined Intravitreal Ranibizumab and Photodynamic Therapy for Retinal Angiomatous Proliferation
Lee, M. Y., Kim, K. S., & Lee, W. K. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.01.028 · Cited by 47
Unraveling A Complex Genetic Disease: Age-related Macular Degeneration
Chamberlain, M., Baird, P. N., Dirani, M., & Guymer, R. H. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.08.003 · Cited by 42
Gharbiya, M., Parisi, F., Cruciani, F., Pantaleoni, F. B., Pranno, F., & Abdolrahimzadeh, S. (2013) · Retina · doi:10.1097/iae.0b013e3182979e62 · Cited by 40
Polypoidal choroidal vasculopathy
CIARDELLA, A., Donsoff, I., & Yannuzzi, L. A. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(02)00053-6 · Cited by 39
Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
van Asten, F., Rovers, M. M., Lechanteur, Y. T. E., Smailhodzic, D., Muether, P. S., Chen, J., den Hollander, A. I., Fauser, S., Hoyng, C. B., van der Wilt, G. J., et al. (2014) · Ophthalmic Epidemiology · doi:10.3109/09286586.2014.949010 · Cited by 37
Moon, D. R. C., Lee, D. K., Kim, S. H., You, Y. S., & Kwon, O. W. (2015) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2015.29.4.226 · Cited by 37
Retinal angiomatous proliferation or retinal anastomosis to the lesion
Scott, A. W., & Bressler, S. B. (2009) · Eye · doi:10.1038/eye.2009.311 · Cited by 37
Asian Age-Related Macular Degeneration: Current Concepts and Gaps in Knowledge
Lim, L. S., Cheung, C. M. G., & Wong, T. Y. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31827ff5bc · Cited by 37
ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
Hara, C., Sawa, M., Sayanagi, K., & Nishida, K. (2015) · Retina · doi:10.1097/iae.0000000000000767 · Cited by 34
Retinal Anastomosis to Choroidal Neovascularization
Bressler, N. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.12.1741 · Cited by 33
Rouvas, A. A., Chatziralli, I. P., Theodossiadis, P. G., Moschos, M. M., Kotsolis, A. I., & Ladas, I. D. (2012) · Retina · doi:10.1097/iae.0b013e318235d8ce · Cited by 30
Ferrone, P. J., Anwar, F., Naysan, J., Chaudhary, K. M., Fastenberg, D. M., Graham, K., & DERAMO, V. A. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304474 · Cited by 30
Kent, J. S., Iordanous, Y., Mao, A. J., Powell, A.-M., Kent, S. S., & Sheidow, T. (2012) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2012.01.003 · Cited by 29
Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
Yazdi, M. H., Faramarzi, M. A., Nikfar, S., Falavarjani, K. G., & Abdollahi, M. R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1057565 · Cited by 25
Aslankurt, M., Aslan, L., Aksoy, A., Erden, B., & Çekıç, O. (2013) · European Journal of Ophthalmology · doi:10.5301/ejo.5000268 · Cited by 25
Hu, Z., Xie, P., Ding, Y., Yuan, D., & Liu, Q. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305488 · Cited by 25
Time Trends in the Incidence and Causes of Blindness in Israel
Belkin, M., Kalter‐Leibovici, O., Chetrit, A., & Skaat, A. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.09.017 · Cited by 25
Hall, L. B., Zebardast, N., Huang, J. J., & Adelman, R. A. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0188 · Cited by 21
Outer retinal cysts in age-related macular degeneration
Wolff, B., Maftouhi, M. Q.-E., Mateo-Montoya, A., Sahel, J., & Mauget‐Faÿsse, M. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02144.x · Cited by 21
Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab
Almony, A., Mansouri, A., Shah, G. K., et al. (2011) · Canadian Journal of Ophthalmology · doi:10.3129/i10-095 · Cited by 20
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Criswell, M. H. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.7.946 · Cited by 18
Avgikos, K. N., Horgan, S., Sivaraj, R. R., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.040 · Cited by 16
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema
Morjaria, R., & Chong, V. N. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.922543 · Cited by 13
Resistance, not tachyphylaxis or tolerance
Arjamaa, O., & Minn, H. R. I. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-301823 · Cited by 12
Pinheiro-Costa, J., Freitas‐da‐Costa, P., Falcão, M. S., Brandão, E., Falcão‐Reis, F., & Carneiro, Â. M. (2014) · Ophthalmologica · doi:10.1159/000363422 · Cited by 11
Hirano, Y., Yasukawa, T., Tsukada, A., Yokoyama, S., Ito, Y., & Nakazawa, Y. (2015) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20150323-16 · Cited by 8
Zanke, B. W. (2009) · Evidence-Based Ophthalmology · doi:10.1097/ieb.0b013e3181b93d80 · Cited by 8
Ziemssen, F., Neuhann, I. M., & Voelker, M. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.038 · Cited by 3
Cited by
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 512
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
Boopathy, G. T. K., & Hong, W. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00049 · Cited by 344
The Role of Inflammation in Age-Related Macular Degeneration
Tan, W., Zou, J., Yoshida, S., Jiang, B., & Zhou, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49890 · Cited by 311
Wang, X., Fan, W., Li, N., Ma, Y., Yao, M., Wang, G., He, S., Li, W., Tan, J., Lu, Q., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02931-y · Cited by 288
The tspo-nox1 axis controls phagocyte-triggered pathological angiogenesis in the eye
Wolf, A., Herb, M., Schramm, M., & Langmann, T. (2020) · Nature Communications · doi:10.1038/s41467-020-16400-8 · Cited by 80
Metadata
- Authors
- Sun, X., Yang, S., & Zhao, J.
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2016-06
- Volume
- 10
- Pages
- 1857
- ISSN
- 1177-8881 (ISSN-L)
- OpenAlex
- W2412434883
- Cited by
- 347
- References
- 132
- FWCI
- 20.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.